Kasian Franks is the founder, Chief executive officer CEO , and CVO Disambiguation needed date June 2011 of Mimvi . Career Franks was born and raised in Berkeley California . At UC Berkeley , he studied Computer Science and Software Engineering . While at UC Berkeley, Franks consulted for Genentech and eventually started his own company in 1993, The Berkeley Integration Group , which later landed Genentech as its first client. While working with Genentech, Franks helped develop and manage the Pharmaceutical Recipe Builder PRB , a toolset for construction and revision control of genetic recipes used to design breast cancer, asthma and blood clotting drugs HER2, DNASE and Protein A . ref http lmi.seeqpod.com kasian franks CV KF.html ref Franks worked as software engineer and product developer specializing in pattern matching algorithms and tools for companies and organizations such as Sun Microsystems , Oracle Corporation Oracle , Motorola , Tivo , mPower , and X Mine . Franks worked at the U.S. Department of Energy s Lawrence Berkeley National Laboratory LBNL , Life Sciences Division, as a Genomic Research Scientist from 2002 2005, where, along with Raf Podowski, and Connie Myers, he developed the technology behind SeeqPod . Franks began to study biomimetics along with pattern matching in data and nature. This led to 5 patents in the area of search and discovery. Later he went on to start SeeqPod Inc. a music search, discovery and pattern matching company in which the U.S. Department of Energy , along with Lawrence Berkeley National Laboratory , holds a 5 stake. Under Steven Chu and Lawrence Berkeley National Lab , Franks and SeeqPod won a 2008 R&D 100 Award for biomimetic search engines . A number of record companies have attempted to sue SeeqPod, including Warner Music Group , Elektra Records , Rhino Records , and most recently EMI and Capitol Records . ref http www.eff.org deeplinks 2008 01 latest test dmca safe harbors warner sues seeqpod ref Franks formerly held ... more details
Herbert W. Boyer born July 10, 1936 is a recipient of the 1990 National Medal of Science , co recipient of the 1996 Lemelson MIT Prize , and a co founder of Genentech . He served as Vice President of Genentech from 1976 through his retirement in 1991. ref name Boyer cite news url http www.time.com time covers 1101030217 scdprofile2.html title The Pioneers of Molecular Biology Herb Boyer publisher Time Magazine, March 9, 1981 cover of TIME date February 9, 2002 accessdate May 4, 2010 ref Life and career Boyer was born in Derry, Pennsylvania . He received his bachelor s degree in biology and chemistry from Saint Vincent College in Latrobe, Pennsylvania , in 1958. He married his wife Grace the following year. He received his PhD at the University of Pittsburgh in 1963 and participated as an activist in the civil rights movement. He spent three years in post graduate work at Yale University in the laboratories of Professors Edward Adelberg and Bruce Carlton, then became an assistant professor at the University of California, San Francisco and a Professor of Biochemistry from 1976 to 1991, where he discovered that genes from bacteria could be combined with genes from eukaryote s. In 1977, Boyer s laboratory and collaborators at City of Hope National Medical Center described the first ever synthesis and expression of a peptide coding gene. ref http www.ncbi.nlm.nih.gov pubmed 412251 Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science. 198 4321 1056 63. ref In August 1978, he produced synthetic insulin using his new transgenic genetically modified bacteria , followed in 1979 by a growth hormone . In 1976, Boyer founded Genentech with venture capitalist Robert A. Swanson . Genentech s approach to the first synthesis of insulin won out over Walter Gilbert Wally Gilbert s approach at Biogen which used gene s from natural sources. Boyer created his gene de novo from its individual nucleotide s. In 1990 April, Boyer and his wife ... more details
refimprove date October 2009 Regis McKenna is best known for helping start several Silicon Valley firms during the 1970s and 1980s with his own marketing firm, Regis McKenna, Inc. , founded in 1970. ref http www.regis.com Regis McKenna official website . ref McKenna retired from consulting in 2000 and is concentrating his efforts on high tech entrepreneurial seed ventures. McKenna and his firm worked with a number of Start up company start up companies during their formation years including America Online , Apple Inc. Apple , Compaq , Electronic Arts , Genentech , Intel , Lotus Software , Microsoft , National Semiconductor , Silicon Graphics , 3COM , and others. References reflist Persondata Metadata see Wikipedia Persondata . NAME Mackenna, Regis ALTERNATIVE NAMES SHORT DESCRIPTION DATE OF BIRTH PLACE OF BIRTH DATE OF DEATH PLACE OF DEATH DEFAULTSORT Mackenna, Regis Category Year of birth missing living people Category Living people Category American computer businesspeople Category Silicon Valley people US business bio stub bg fi Regis McKenna ... more details
Tuas Biomedical Park abbreviation TBP is a biomedical manufacturing cluster developed by JTC Corporation at the western end of Singapore . The 183 hectare Tuas Biomedical Park I and 188 hectare Tuas Biomedical Park II are located at Tuas View 20 minutes away from Jurong Port and five minutes from the Tuas Checkpoint to Malaysia . TBP comes with all essential infrastructure, such as roads, power lines, telecommunication lines, sewer pipes and water and gas supplies. Third parties are providing utilities such as steam, natural gas, chilled water and waste treatment services. To improve the appearance of the industrial estate, JTC has spent 6 million on lush landscaping. With the estate s plug and play design, pharmaceutical, biologics, medical device and other biomedical companies can set up manufacturing operations with minimal lead time. They can either move into fully serviced facilities or custom build their own manufacturing plants. Currently, there are many well known companies operating in TBP. They include global biomedical players like Merck & Co. Merck , Novartis , Pfizer , Wyeth , Genentech and GlaxoSmithKline . External links http www.jtc.gov.sg portfolio TuasBioMedicalPark Pages index.aspx Tuas Biomedical Park at JTC Corporation coord missing Singapore Category Industrial parks in Singapore Category Tuas ... more details
infobox journal title Contemporary Clinical Trials cover File Contemporary Clinical Trials.gif abbreviation Contemp. Clin. Trials formernames Controlled Clinical Trials discipline Clinical trial s editor Zheng Su publisher Elsevier country history 1980 present frequency Bimonthly impact 1.698 impact year 2010 website http www.journals.elsevier.com contemporary clinical trials description link1 http www.sciencedirect.com science journal 15517144 link1 name Online access link2 http www.sciencedirect.com science journal 01972456 link2 name Online access to Controlled Clinical Trials ISSN 1551 7144 eISSN 1559 2030 LCCN 80645055 OCLC 56090329 CODEN CCLTDH Contemporary Clinical Trials is a bimonthly Peer review peer reviewed medical journal covering clinical trial trials and research design design in clinical medicine . It was established in 2005 and is published by Elsevier . The editor in chief is Zheng Su Genentech . it was established in 1980 as Controlled Clinical Trials and obtained its current title in 2005. External links Official http www.journals.elsevier.com contemporary clinical trials description med journal stub Category General medical journals Category Elsevier academic journals Category English language journals Category Bimonthly journals Category Publications established in 1980 ... more details
BLP sources date February 2011 Randall Caudill is president and founder of Dunsford Hill Capital Partners, a San Francisco based financial consulting firm serving early stage health care and technology companies. Caudill serves on VaxGen board s Audit Committee and Compensation Committee and the Genentech Contract Committee. From 1987 to 1997, Caudill was employed by Prudential Securities , where he established and headed the firm s San Francisco investment banking practice. He also served as head of Prudential s Mergers and Acquisitions Department and co head of the investment bank. A native of Harlan, Iowa, where his father was a well known and respected dentist, Randall received a Ph.D. from Oxford University , where he was a Rhodes Scholar, a masters degree in Public and Private Management from Yale University , and a bachelor of arts from the College of the Holy Cross . ref http investing.businessweek.com businessweek research stocks private person.asp?personId 612470&privcapId 36170&previousCapId 36170&previousTitle VaxGen 20Inc. Bloomberg Businessweek, Executive Profile ref References reflist Persondata Metadata see Wikipedia Persondata . NAME Caudill, Randall ALTERNATIVE NAMES SHORT DESCRIPTION DATE OF BIRTH PLACE OF BIRTH DATE OF DEATH PLACE OF DEATH DEFAULTSORT Caudill, Randall Category Living people Category Alumni of the University of Oxford Category American businesspeople ... more details
Chemdex.com was one of the first online business to business B2B e commerce companies. Based in the United States , Chemdex provided an online marketplace for sales of chemicals, enzymes, lab equipment, biotech products like peptides, and many types of chemical reagents. Once an IPO darling of Wall Street, it was never profitable and it became one of many companies destroyed in the dot com crash of the early 2000s. Chemdex was started in 1997 by former Exxon engineer David Perry in Palo Alto, California , and received venture capital from Genentech founder Robert A. Swanson , and from VC firms Kleiner Perkins Caufield & Byers and CMGI CMGI Ventures . Chemdex s flotation on the NASDAQ exchange in July 1999 ticker symbol CMDX now disused was typical of other initial public offering s of dot com companies during the dot com bubble . At the time Chemdex recorded quarterly sales of 165,000, mostly to Genentech, and had lost 6.8 million in the same quarter. Yet it raised 112.5 million at IPO, and its stock rose 60 on the first day, valuing the whole company including those shares still privately held at over 750 million . ref http news.com.com Chemdex shines on market debut 2100 1017 3 229160.html Chemdex shines on market debut news.com July 28, 1999, URL retrieved 18 June 2006 ref Chemdex spawned its own parent, Ventro Corporation. Ventro merged with a number of related businesses, including Specialty MD and Promedix both specialty medical technology providers and engaged in joint ventures with Tenet Healthcare and VWR Scientific. By 2000 the company s market capitalization had grown to over 4 billion. ref The Days and Nights of David Perry , In Vivo The Business & Medicine Report February 2000, URL retrievd 18 June 2006 ref When, as with other similar companies, investors lost confidence in highly priced but unprofitable internet ventures, Ventro s stock plummeted to only 1 of its previous value, and unable to find a buyer for the business Ventro shut its Chemdex divisi ... more details
Infobox scientist name Rakesh K. Jain image image size alt caption birth date birth place death date death place residence United States citizenship nationality fields workplaces Harvard Medical School , Massachusetts General Hospital alma mater University of Delaware , Indian Institute of Technology, Kanpur doctoral advisor James Wei academic advisors Pietro M. Gullino doctoral students notable students known for Tumor pathophysiology author abbrev bot author abbrev zoo influences influenced awards signature filename only signature alt footnotes Rakesh K. Jain is the Andrew Werk Cook Professor of Tumor Biology at Massachusetts General Hospital in the Harvard Medical School . Dr. Jain primarily researches tumor pathophysiology . His work on cancer therapies led to discovery of an alternate use of Herceptin , an anti tumor cell pharmaceutical compound produced by Genentech , as an inhibitor for blood vessel growth necessary for tumor growth. ref http query.nytimes.com gst fullpage.html?sec health&res 9A04EFDA1038F932A15750C0A9649C8B63&n Top 2fReference 2fTimes 20Topics 2fOrganizations 2fH 2fHarvard 20University 20 Study Said to Show Added Benefit of Genentech Breast Cancer Drug . Andrew Pollack. New York Times . Retrieved January 17, 2007. ref His award winning work on tumor biology has been recognized by a number of professional recognitions, including the following awards in 2006 Distinguished Service Award, Nature Biotechnology Miami Symposium on Angiogenesis Outstanding Achievement Award, Society of American Asian Scientists in Cancer Research Robert L. Krigel Lecture, Fox Chase Cancer Center, Philadelphia Alpha Chi Sigma Research Award, American Institute of Chemical Engineers Benjamin Zweifach Distinguished Lecture, The City College, New York Dr. Jain received his B.Tech. degree from the Indian Institutes of Technology in Chemical Engineering in 1972 and received his M.Ch.E. and Ph.D. in Chemical Engineering from the University of Delaware in 1974 and 1976, res ... more details
For the biotechnology company Genentech Unreferenced date February 2007 Genetech is a fictional corporation in the Marvel Comics universe. It is located in Sayville, New York Sayville, Long Island in the state of New York. Genetech is involved in many scientific endeavors and appears as both an ally and an adversary of the superhuman team the New Warriors . Genetech should not be confused with the real corporation Genentech . The CEO of Genetech is Walter Rosen. Genetech was founded by Harmon Furmintz who ran the company until he absorbed the energy of Terrax , the former herald of Galactus. He was ultimately consumed by it. In 1940, Harmon participates in a top secret government project. He is rejected from it for being a hemophiliac . Although he was never able to find proof, he believes it is the same project that resulted in the creation of Captain America . Later, Harmon works with Howard Stark, the father of Iron Man . He becomes a teacher to the young Reed Richards , who would later form the Fantastic Four . Much of Genetech s funding came from the Taylor Foundation via illegal grants set up by Night Thrasher s guardians Tai comics Tai and Andrew Chord . Tai and Chord were also responsible for murdering Night Thrasher s parents. Walter Rosen also served on the board of directors of the Taylor Foundation after Tai was killed and Night Thrasher assumed full control of the Taylor Foundation. Psionex In New Warriors 3 Genetech hired the Mad Thinker to gather data on the Warriors that they used to create their own superpowered individuals nicknamed Psionex . The team did not work well with others. For example, Pretty Persuasions kept seducing the people assigned to keep an eye on her, no matter the gender. Genetech had a hard time simply keeping the team on the premises. The team came into conflict with the New Warriors again and again. The first conflict arose when the New Warriors investigate why Genetech is investigating them. The resulting fights cause slight damage ... more details
Infobox person name Susan Desmond Hellmann image alt in 2010 in Seattle caption birth date Birth date YYYY MM DD birth place death date Death date and age YYYY MM DD YYYY MM DD death date then birth date death place nationality other names known for public health occupation Chancellor education chancellor Susan Desmond Hellmann , MD, MPH, is currently the Chancellor of the University of California, San Francisco . She was appointed to the position by UC President Mark Yudof on May 7, 2009, and officially took over in the position on August 3, 2009. ref name UCSFPub 1 cite web url http www.ucsfhealth.org adult health library news 2009 05 121510.html accessdate 2009 08 03 title UCSF press release ref She served as president of New product development product development at Genentech from March 2004 through April 30, 2009. In this role, Desmond Hellmann was responsible for Genentech s development, process research and development , business development , Product management product portfolio management , alliance management, and pipeline planning support functions. Desmond Hellmann also served as a member of Genentech s executive committee, beginning in 1996. Career Desmond Hellmann joined Genentech in 1995 as a clinical scientist, and she was named Chief Medical Officer chief medical officer in 1996. In 1999, Desmond Hellmann was named executive vice president of development and product operations. Desmond Hellmann is board certified in internal medicine and Oncology medical oncology , and completed her clinical training at UCSF following completion of a Bachelor of Science bachelor of science degree in premedicine and a Doctor of Medicine medical degree at University of Nevada, Reno . She also holds a master s degree in public health from University of California, Berkeley . Prior to joining Genentech, Desmond Hellmann was associate director of clinical cancer research at Bristol Myers Squibb Pharmaceutical Research Institute. While at Bristol Myers Squibb, she was th ... more details
USAN council Infinity IPI 926 saridegib, Genentech GDC 0449 vismodegib, and Novartis LDE 225 erismodegib . Although Infinity is further along in chondrosarcoma, myelofibrosis, and AML, Roche Genentech ... it priority review status. Thus it appears that Roche Genentech will be the first Hhi to market with GDC ... web url http www.gene.com gene pipeline current title Genentech Pipeline publisher Genentech ref ... more details
2011 03 22?utm medium rss&utm source rss ref Hoffmann La Roche Roche Genentech ref name Feb2011 ... genentech what about immunogen title As Seattle Genetics Strengthens Its Foothold Within Genentech ... Inc of Waltham, Massachusetts, in deals with Novartis and Roche Genentech for their tumor activated ... ref of London, UK, in deals with Genentech , ref http www.news medical.net news 20110107 Spirogen Genentech enter multi year ADC research collaboration and license agreement.aspx ref Approvals and indications ... DM1 29 BLA for metastatic breast cancer.aspx title FDA denies accelerated approval of Genentech s trastuzumab ... more details
as the Chair of the Mayor s HIV Task Force. In 1993, Francis joined Genentech, Inc. , of South San ... Nowinski spun off Genentech s HIV vaccine unit, after the company had disappointing results, and founded ... more details
program under a tripartite partnership formed by Tanox, Novartis , and Genentech in 1996. The problem ... from Genentech and Novartis, and the three companies plan to focus on researching Xolair for use ... more details
AIDSVAX is an experimental HIV vaccine that was developed originally at Genentech in San Francisco, California , and later tested by the VaxGen company, a Genentech offshoot. ref name pmid12848591 cite journal author title HIV gp120 vaccine VaxGen AIDSVAX, AIDSVAX B B, AIDSVAX B E, HIV gp120 vaccine Genentech, HIV gp120 vaccine AIDSVAX VaxGen, HIV vaccine AIDSVAX VaxGen journal Drugs R D volume 4 issue 4 pages 249 53 year 2003 pmid 12848591 doi url last1 Adis International first1 Ltd ref The development and trials of the vaccine received significant coverage in the international media, but American trials proved inconclusive. The vaccine was then tested on a group of at risk individuals in Thailand . In 1991, AIDSVAX originally consisted of the B envelope of recombinant gp120 , a glycoprotein unique to HIV s surface, from a strain of the virus , MN, known at the time to infect people in the United States and Europe . The vaccine was designed to provoke the production of antibodies in subjects that would strip the gp120 protein off of the HIV viral particles, effectively disabling the virus so that it could not bind to or invade susceptible cell biology cell s. Then, another group, infected with a second strain of HIV, A244, was discovered in 1995, and a revised, bivalent version of the vaccine was produced that combined elements of both MN and A244. Phase I and Phase II tests of the first version were promising, showing excellent safety in chimpanzees and humans and provoking production of HIV MN and A244 antibodies in 99 of human volunteers. ref name Eaton Eaton ML. VaxGen Fighting the AIDS Epidemic. Ethics and the Business of Bioscience . Stanford Stanford University Press, 2004. ref VaxGen s leadership enthusiastically applied to the U.S. Food and Drug Administration FDA for permission to undertake Phase III studies in the U. S. on large numbers of at risk volunteers. But since some of the Phase I and Phase II volunteers had become infected with HIV while taking the vaccine ... more details
by Tanox, now part of Genentech . As part of Genentech s takeover of Tanox, the patent for ibalizumab ... news url http seekingalpha.com article 47462 genentech partners with taiwan company on aids drug title Genentech Partners with Taiwan Company on AIDS Drug work Seeking Alpha date 2007 09 18 ref ref cite ... more details
trials due to lack of funds, which caused some controversy. ref name Lancet In 1997, Alteon and Genentech announced a collaboration agreement under which Genentech would fund development of Pimagedine ... News article.cfm?SourceCode 19981116faq ref In February, 1999, Genentech ended its collaboration ... more details
received a 300,000 grant from the Genentech Foundation to provide support through their Everyday Needs Assistance program in April 2009. ref name Genentech http andreriveroflife.org wp content uploads 2009 06 genentechpressrelease.pdf Genentech Provides 300,000 Grant ref In summer 2008, the Andre ... more details
Levinson is a surname, and may refer to persons Arthur D. Levinson b. 1950 , President of Genentech Barry Levinson b. 1942 , American screenwriter director Daniel Levinson , psychologist Dennis Levinson , New Jersey politician Eric L. Levinson , North Carolina judge Feodor Levinson Lessing 1861 1939 , Russian geologist Gerald Levinson b. 1951 , American composer Jerrold Levinson b. 1948 , American Ph.D. in Philosophy Joel Moss Levinson , Internet personality Marcus Levinson 1887 1933 , French dance journalist Nathan Levinson , American sound engineer Norman Levinson 1912 1975 , American mathematician who in 1947 proposed the Levinson recursion Levinson Durbin algorithm Paul Levinson b. 1947 , American author Richard Levinson 1934 1987 , American writer and producer Robert Levinson , missing American private detective Sam Levinson actor Sam Levinson , American actor Stephen C. Levinson , linguist Steven H. Levinson b. 1946 , Associate Justice of the Hawaii State Supreme Court as well as Jonathan Levinson , a fictional character Mark Levinson , audio company Levinsohn and Lewinsohn are variants and may refer to Isaac Baer Levinsohn , Russian Hebrew scholar and writer Joshua Lewinsohn 1833 ? , Russian teacher and writer Ross Levinsohn , former President of Fox Interactive Media, the Internet and New Media arm of News Corporation See also Levison Levenson surname Category Jewish surnames Category Levitic surnames de Levinson fa fr Levinson he ru uk ... more details
Infobox Company company name Rutherford & Chekene company type Private foundation 1960 by John Rutherford and Constantine Chekene location San Francisco industry Consultant engineering consulting operating income homepage http www.ruthchek.com www.ruthchek.com Rutherford & Chekene is a structural and geotechnical engineering firm in California specializing in new design and retrofit of structures for clients in healthcare, higher education, research and development, art and education, and technology. Rutherford & Chekene began implementing 3 D modeling to produce Building information modeling building information models BIM in 2005. Because of the remarkable results of this technology, R&C has now developed more than 3 billion in construction using BIM created with Revit and other software. Notable projects http www.revitcommunity.com print article.php?cpfeatureid 61998 UC Merced Science and Engineering Building 2 , Merced http www.sfgate.com cgi bin article.cgi?f c a 2011 04 09 MNIL1ISD7C.DTL New Exploratorium , San Francisco http www.businesswire.com news home 20110809005777 en Wind Tunnel Testing Reveals Challenges Opportunities Rooftop Designing for Wind Loads on Solar Arrays , California M. H. de Young Memorial Museum De Young Museum , San Francisco Monterey Bay Aquarium , Monterey Monterey Bay Aquarium Research Institute , Moss Landing Renovation and expansion of the UC Santa Cruz McHenry Library , Santa Cruz Genentech Hall, QB3, and hospital at the UCSF Mission Bay, San Francisco, California Mission Bay campus Pixar Animation Studios, Emeryville References reflist Gonchar, Joann. One Project, but Many Seismic Solutions , Architectural Record. Talarico, Wendy. Seismic Systems that Stand Up to Nature , Architectural Record , February 2000. Category Business services companies of the United States Category Companies established in 1960 Category Engineering companies of the United States US corp stub ... more details
about the book comedy series of 1971 The Partners Infobox Book name The Partners Inside America s Most Powerful Law Firms title orig translator image Image The partners cover.JPG 130px border The Partners image caption Front Cover author James B. Stewart illustrator cover artist country Image Flag of the United States.svg 20px United States language English language English series subject Law genre publisher Simon & Schuster release date 1983 english release date media type Hardcover pages 395 isbn 0 671 42023 2 dewey 338.7 6134973 s 338.7 613473 19 congress KF300 .S73 1983 oclc 8785200 preceded by followed by Prosecutors The Partners Inside America s Most Powerful Law Firms 1983 is a bestselling book by James B. Stewart . The book is a product of two years of investigation of the role of prominent law firms in society. The book describes and discusses several famous cases. There have been five editions of the book as of 2008. ref http www.worldcat.org oclc 8785200&referer brief results www.worldcat.org ref Contents Part One. Iran hostage crisis Iran Shearman & Sterling , Davis Polk & Wardwell Part Two. IBM Cravath, Swaine & Moore Part Three. Genentech Pillsbury, Madison & Sutro Part Four. Westinghouse Electric Company Westinghouse Kirkland & Ellis Part Five. Chrysler Debevoise & Plimpton Debevoise, Plimpton, Lyons & Gates Part Six. Kennecott Utah Copper Kennecott Sullivan & Cromwell Part Seven. Rockefeller family Rockefeller Milbank, Tweed, Hadley & McCloy Part Eight. Kodak Donovan, Leisure, Newton & Irvine Official information cite book author Stewart, James title The Partners Inside America s Most Powerful Law Firms publisher Simon & Schuster location New York year 1983 id ISBN 0 671 42023 2 References Reflist External links http www.roycecarlton.com speakers stewart bio.html Author, Editor at Large & Columnist, Smart Money http www.anderson.ucla.edu x15009.xml UCLA James B. Stewart http www.librarything.com work 242742 www.librarything.com DEFAULTSORT Partners, ... more details
Infobox SCOTUS case Litigants Altvater v. Freeman ArgueDate April 19 ArgueYear 1943 DecideDate May 24 DecideYear 1943 FullName Altvater v. Freeman USVol 319 USPage 359 Citation 319 U.S. 359 Prior Subsequent Holding Although a licensee had maintained payments of royalties, a Declaratory Judgment Act claim of invalidity of the licensed patent still presented a justiciable case or controversy. SCOTUS 1943 1945 Majority Douglas JoinMajority Concurrence JoinConcurrence Concurrence2 JoinConcurrence2 Concurrence Dissent JoinConcurrence Dissent Dissent JoinDissent Dissent2 JoinDissent2 LawsApplied Altvater v. Freeman , 319 U.S. 359 1943 , was a decision by the Supreme Court of the United States which held that, although a licensee had maintained payments of royalties, a Declaratory Judgment Act claim of invalidity of the licensed patent still presented a justiciable case or controversy. See also List of United States Supreme Court cases, volume 319 MedImmune, Inc. v. Genentech, Inc. , ussc 549 118 2007 Further reading cite journal last Maines first Ruanne Neighbour authorlink coauthors year 1949 month title Declaratory Judgments Patent Litigation Justiciable Controversy journal California Law Review volume 37 issue 3 pages 506&ndash 510 doi 10.2307 3477809 quote publisher California Law Review, Vol. 37, No. 3 jstor 3477809 External links wikisource http caselaw.lp.findlaw.com scripts getcase.pl?navby CASE&court US&vol 319&page 359 Full text opinion from Findlaw.com Category United States Supreme Court cases Category United States patent case law Category 1943 in United States case law SCOTUS case stub ... more details
Encyclopedia
top
